Rudnick
Andreas Rudnick, Malschwitz DE
Patent application number | Description | Published |
---|---|---|
20140268983 | OTPROM ARRAY WITH LEAKAGE CURRENT CANCELATION FOR ENHANCED EFUSE SENSING - Disclosed herein are memory cell arrays and methods for operating memory cell arrays. In one embodiment, a memory cell array includes a plurality of bitcells, a first bitline, a second bitline, a first wordline and a second wordline. The bitcells are arranged into rows and columns and each include a first transistor, a second transistor, and a fuse with a first end and a second end. The second transistor is selectively operable to couple the first end of the fuse to a ground. The first bitline is coupled to the first transistor of each of the bitcells of one column. The second bitline is coupled to the second end of the fuse of each of the bitcells of the column. The first transistor of each of the bitcells of the column is selectively operable to couple the first end of the fuse to the first bitline. | 09-18-2014 |
Dieter Rudnick, Dreieich DE
Patent application number | Description | Published |
---|---|---|
20130045199 | Antibody Preparations - An antibody preparation suitable for intravenous administration in humans includes IgG, IgA and at least 5% IgM antibodies by weight of the total amount of antibodies. The preparation is prepared from human plasma, has specific complement activating activity, and, in an in vitro assay with human serum suitable to determine the ability of the antibody preparation to activate complement unspecifically, the antibody preparation generates substantially no C5 | 02-21-2013 |
20150064170 | Antibody Preparations - An antibody preparation suitable for intravenous administration in humans includes IgG, IgA and at least 5% IgM antibodies by weight of the total amount of antibodies. The preparation is prepared from human plasma, has specific complement activating activity, and, in an in vitro assay with human serum suitable to determine the ability of the antibody preparation to activate complement unspecifically, the antibody preparation generates substantially no C5a and/or substantially no C3a. The antibody preparation can have medical uses. | 03-05-2015 |
Juergen Rudnick, Gruendau DE
Patent application number | Description | Published |
---|---|---|
20130253684 | SYSTEM AND METHOD FOR ROBUST REAL-TIME CONTROL OF REGULAR AUTOMATED PRODUCTION - A method includes initializing, at a first controller, at least one process step of a control recipe from a master recipe associated with a batch process in response to detection of an event associated with the batch process. The method also includes executing, at the first controller, the at least one process step of the control recipe. The method further includes initializing, at the first controller, at least one second process step of the control recipe while executing the at least one process step of the control recipe. Initializing the at least one process step of the control recipe from the master recipe may include copying only a portion of the master recipe into the control recipe that is needed to begin execution of the control recipe. | 09-26-2013 |
Jürgen Rudnick, Hesse DE
Patent application number | Description | Published |
---|---|---|
20140121812 | SYSTEM AND METHOD FOR VENDOR RELEASE INDEPENDENT REUSABLE CUSTOMIZED FUNCTION BLOCK LIBRARIES - A method includes obtaining instructions for a customized function block in a parametric block type. The method also includes developing, at a parametric block engine, the customized function block based on the instructions in the parametric block type. The method further includes executing the customized function block. Executing the customized function block may include executing the customized function block using firmware associated with a controller in a process control system. The parametric block engine may be pre-loaded into the controller before the controller is activated in the process control system. | 05-01-2014 |